Full-Time

Territory Manager

SI-BONE

SI-BONE

501-1,000 employees

Minimally invasive sacroiliac joint implant provider

Compensation Overview

$100k/yr

Chicago, IL, USA

In Person

Category
Sales & Account Management (1)

Get referred to SI-BONE

See people who can refer or advise you

Requirements
  • Bachelor’s degree and currently or recently served in sales territory management position of a high-growth, medical device organization whose products are marketed to a medical specialty practice and worked in that capacity for a minimum of 5 years
  • Experience in Orthopedics or Pain Management is highly desired
  • Spine experience also a plus
  • Have experience working with local Pain Physicians or Spine Surgeons and product advocates
  • Have a demonstrated ability to communicate effectively and work well with senior management
  • Have a consistent career history of strong, effective leadership, a self-starter attitude and team building
  • Be a positive, self-confident, decisive team member who has excellent communication skills in both oral and written formats, as well as excellent listening skills
  • Be a pro-active person who attacks problems, displaying initiative and perseverance in order to bring about meaningful change, and to be open and responsive to new ideas
  • Be known as a person who has high integrity, sound character, a tremendous work ethic and the passion to succeed
  • Knowledge and familiarity of applicable regulations/standards (e.g. ISO 13485, FDA 21 CFR 820, EU MDR 2017/745, ISO 14971) as required to perform the job function
Responsibilities
  • Reports to the hiring Regional Sales Director and has responsibility for managing the specific territory
  • Provide leadership and performance to ensure that company goals are achieved
  • Target, qualify, and train key Interventional physicians scheduling cases to implant SI-Bone Products
  • Coordinate training of all local interventional physicians in the assigned territory
  • Meet goals and quotas communicated by the Regional Sales Director
  • Meet with key opinion leaders in pain and spine to drive company business and acceptance of SIJ diagnosis and treatment
  • Coordinate the hospital approval process and the referring physician education programs to the local communities of referring physicians
  • Responsible for performing all duties in compliance with all applicable worldwide regulatory requirements as included in the scope of the SI-BONE Quality Manual
  • The Territory Manager must at all times act and conduct company business in an honest, ethical and strictly legal manner, complying with the Code of Conduct, other company policies, the AdvaMed Code and all applicable laws and regulations, whether national, regional, state or local. This employee is encouraged, expected, and required to report any suspected violations of laws, regulations, the Code or any other Company policy, and all other suspected unethical behavior. The company does not tolerate retaliation in connection with making good faith reports of suspected violations
  • Establish rapport and a solid working relationship with the physicians and all employees
  • Manage all travel & entertainment expenses responsibly and within company outlined operating budgets
  • Work closely with sales management to align priorities and create a sense of urgency to ensure successful endpoints are achieved and timelines are met
  • Execute and refine the clinical support, selling, referral education programs and reimbursement strategy
  • Provide the necessary reporting materials and communicate effectively and openly to the Regional Sales Manager & Senior Management Team as required
  • Develop rapport with key leaders in the spine field
  • In-servicing and educating all Nurses and Scrub Technicians in the operating room setup and use of the SI-BONE instruments during SI-Bone procedures
  • Consult with the X-Ray Technicians at hospitals and obtain the necessary images required during all iFuse surgical procedures
  • Answer questions from the implanting physician pertaining to all ifuse procedures during the surgery
  • In-servicing and educating the sterile processing department on the care, handling, and sterilization parameters of the ifuse instrument system
  • Responsible for management of implant shelf life and instrument sets provided to them. Damaged or expired product to be returned to SI-BONE, Inc
  • Provide information to the circulating nurse and operating room purchasing department on implants and disposal items used during all ifuse procedures
  • In the event of potential non-compliance with applicable standards or regulations (e.g. FDA QSRs, ISO 13485 or ISO 14971), the employee has the authority to hold any product or Quality documentation from shipment or further processing. The employee has the responsibility and authority to report any instances to Quality and/or Regulatory and his respective management team
  • Support the SI-BONE Quality System
  • Have a demonstrated ability to communicate effectively and work well with senior management
  • Have a consistent career history of strong, effective leadership, a self-starter attitude and team building
  • Be a positive, self-confident, decisive team member who has excellent communication skills in both oral and written formats, as well as excellent listening skills
  • Be a pro-active person who attacks problems, displaying initiative and perseverance in order to bring about meaningful change, and to be open and responsive to new ideas
  • Be known as a person who has high integrity, sound character, a tremendous work ethic and the passion to succeed
  • Knowledge and familiarity of applicable regulations/standards (e.g. ISO 13485, FDA 21 CFR 820, EU MDR 2017/745, ISO 14971) as required to perform the job function
Desired Qualifications
  • Experience in Orthopedics or Pain Management is highly desired
  • Spine experience also a plus
  • Have experience working with local Pain Physicians or Spine Surgeons and product advocates

SI-BONE focuses on treating sacroiliac joint dysfunction, a common source of lower back pain, by offering a minimally invasive implant system called iFuse. The iFuse Implant System is implanted surgically to stabilize the sacroiliac joint with a less invasive approach that aims for quicker recovery compared to traditional methods. The company gained FDA clearance for this implant, validating its use in patients. In 2018, SI-BONE went public on the NASDAQ, providing capital to expand research, development, and market presence. Its ongoing goal is to improve patient outcomes through education and continued development of sacroiliac joint treatments. Unlike broader orthopedic device makers, SI-BONE specializes in a targeted SI joint solution and builds its business around a single reusable implant technology and related surgical tools.

Company Size

501-1,000

Company Stage

IPO

Headquarters

San Jose, California

Founded

2008

Get referred to SI-BONE

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • 2025 revenue reached $200.9 million, up 20.2% year over year.[12]
  • New products in Europe and Australia expanded SI-BONE's international reach.[12]
  • A proposed CMS payment category could improve reimbursement for iFuse Bedrock Granite.[12]

What critics are saying

  • SI-BONE remains concentrated in one niche sacropelvic franchise.[3][11]
  • U.S. revenue still dominates, leaving results exposed to domestic reimbursement and hospital cycles.[12]
  • Competing minimally invasive SI fusion systems can pressure share and pricing.[3]

What makes SI-BONE unique

  • Founded in 2008, SI-BONE pioneered minimally invasive SI-joint fusion with iFuse.[1][3]
  • It focuses on sacroiliac and adjacent sacropelvic disorders, not broad orthopedics.[3][11]
  • The company is public on Nasdaq under ticker SIBN.[2][7]

Help us improve and share your feedback! Did you find this helpful?

Benefits

Company Equity

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

1%

2 year growth

0%
SI-BONE
May 6th, 2023
SI-BONE Announces Pricing of Public Offering of Common Stock | SI-BONE, Inc.

SANTA CLARA, Calif. , May 04, 2023 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced the pricing of its underwritten public offering of 3,775,000 shares of its common stock at a price

Ortho Consulting Group
Jun 13th, 2022
SI BONE, Inc. launches FDA clearance for iFuse-TORQ

Announces FDA Clearance for Expanded Indication of the iFuse-TORQ® Implant System SANTA CLARA, Calif., June 13, 2022 (GLOBE NEWSWIRE) — SI-BONE, Inc. (SIBN), (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced an FDA clearance for iFuse-TORQ ® for pelvic fracture fixation, including acute, non-acute and non-traumatic fractures.